Improving outcomes in diabetic nephropathy.

Trial Profile

Improving outcomes in diabetic nephropathy.

Phase of Trial: Phase II

Latest Information Update: 09 Mar 2010

At a glance

  • Drugs Losartan (Primary) ; Spironolactone (Primary) ; Lisinopril
  • Indications Diabetic nephropathies; Hypertension; Proteinuria
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 01 Dec 2009 Primary endpoint 'Urinary albumin:creatinine ratio' has been met.
    • 01 Dec 2009 Results published in the Journal of the American Society of Nephrology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top